Nachrichten zur Emergent Biosolutions Aktie

Form 8-K Emergent BioSolutions For: Jul 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola

GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was…

Form 8-K Emergent BioSolutions For: Jul 21

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Emergent BioSolutions to Release Second Quarter 2023 Financial Results and Conduct Conference Call on August 8, 2023

GAITHERSBURG, Md., July 25, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call…

Emergent BioSolutions announces approval from FDA for CYFENDUS vaccine

Earlier known as AV7909, CYFENDUS vaccines efficacy for post-exposure prophylaxis is only based on studies in animal models of inhalational…

Form 8-K Emergent BioSolutions For: Jul 20

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pre-market Movers: BioNexus Gene Lab, Digital World Acquisition, Emergent BioSolutions, Andretti Acquisition, CytoMed Therapeutics

SEOUL (dpa-AFX) - The following are some of the stocks making big moves in Fridays pre-market trading (as of 06.45…

Pre-market Movers: BGLC, DWAC, Emergent BioSolutions, WNNR, GDTC.

SEOUL (dpa-AFX) - The following are some of the stocks making big moves in Fridays pre-market trading (as of 06.45…

Emergent BioSolutions Shares Rise 16% After Cyfendus Approved for Post-Exposure Prophylaxis Use

Emergent BioSolutions Shares Rise 16% After Cyfendus Approved for Post-Exposure Prophylaxis Use...…

Why Emergent BioSolutions Stock Dived by 9% Today

Investors didnt greet news of the CEOs departure warmly....…

Emergent BioSolutions Chief Executive Kramer to Retire

Emergent BioSolutions Chief Executive Kramer to Retire...…

Emergent BioSolutions CEO Robert Kramer to retire immediately

...June 27 (Reuters) - Emergent BioSolutions said on Tuesday that CEO......…

Form 8-K Emergent BioSolutions For: Jun 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Better Recovery-Story Buy: Emergent BioSolutions or Invitae?

Both of these stocks have plummeted more than 50% over the past year....…

Is Emergent BioSolutions Stock a Buy Now?

The deluge of bad news seems to be over, and a recovery could be in the works....…

Why Is Emergent Biosolutions (EBS) Down 21.4% Since Last Earnings Report?

Emergent Biosolutions (EBS) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Down 75%, Can Emergent BioSolutions Turn Things Around?

Has the stock finally bottomed out?...…

Form 8-K Emergent BioSolutions For: May 25

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Emergent BioSolutions For: May 26

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Emergent BioSolutions Stock Inched Slightly Higher Today

Investors approved, if not enthusiastically, their companys latest asset sale....…

Emergent BioSolutions completes $270M sale of travel health business

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Emergent BioSolutions For: May 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bavarian Nordic Completes Acquisition of Travel Vaccine Portfolio from Emergent BioSolutions

COPENHAGEN, Denmark, May 15, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has completed its acquisition of…

Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 25, 2023 at 9:00am EDT

GAITHERSBURG, Md., May 11, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2023…

Emergent BioSolutions (EBS) Q1 2023 Earnings Call Transcript

EBS earnings call for the period ending March 31, 2023....…

Form 8-K Emergent BioSolutions For: May 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Emergent aims to price over-the-counter Narcan at about $50

...(Reuters) - Contract drugmaker Emergent BioSolutions Inc said......…

Emergent BioSolutions to Release First Quarter 2023 Financial Results and Conduct Conference Call on May 9, 2023

GAITHERSBURG, Md., April 19, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call…

Emergent BioSolutions to amend credit agreement

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Emergent BioSolutions For: Apr 17

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Emergent Biosolutions Upgraded After FDA Approves Narcan OTC Sales

The biotech plans to launch the over-the-counter product this summer, beating competitors to the punch....…

Why Emergent BioSolutions Stock Is Soaring Today

Emergent received a key approval from the FDA, but just how good is this news?...…

Emergent Biosolutions (EBS) Surges 5.1%: Is This an Indication of Further Gains?

Emergent Biosolutions (EBS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions…

Opioid overdose antidote Narcan will be available over-the-counter by late summer after FDA approval

Emergent BioSolutions stock gains after FDA approves the company's opioid overdose-reversing nasal spray, Narcan, for over-the-counter sales....…

FDA Approves Narcan for Over-the-Counter Use. Emergent Biosolutions Surges.

The nasal spray treats opioid overdoses and will now be available for over-the-counter purchases....…

Form 8-K Emergent BioSolutions For: Mar 29

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Emergent BioSolutions Stock Rises 17% on FDA Narcan Approval

Emergent BioSolutions Stock Rises 17% on FDA Narcan Approval...…

Form 8-K Emergent BioSolutions For: Mar 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Emergent Biosolutions Shares Down 14% After JP Morgan Downgrade to Underweight

Emergent Biosolutions Shares Down 14% After JP Morgan Downgrade to 'Underweight'...…

Why Emergent BioSolutions Stock Is Sinking Today

Investors reacted negatively to an analysts downgrade of the healthcare stock....…

Emergent BioSolutions up 5% after institutional investor, hedge fund buys

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Emergent BioSolutions Stock Tumbled by Almost 12% Today

Its not a good day for investors when their company reports a shocking plunge into the red....…

Emergent BioSolutions (EBS) Q4 2022 Earnings Call Transcript

EBS earnings call for the period ending December 31, 2022....…

Emergent Biosolutions (EBS) Reports Q4 Loss, Tops Revenue Estimates

Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -196.88% and 7.47%, respectively, for the quarter ended December 2022. Do…

Emergent Biosolutions Q4 results mixed, co guides FY 2023 revenue in-line

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022

GAITHERSBURG, Md., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…

Emergent Biosolutions Q4 2022 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bavarian Nordic: Kapitalerhöhung – so reagiert die Aktie

Der europäische Impfstoff-Entwickler hat vor wenigen Tagen die Übernahme des Reiseimpfstoff-Geschäfts von Emergent Biosolutions bekanntgegeben. Kostenpunkt: bis zu 380 Millionen…

Analysts Estimate Emergent Biosolutions (EBS) to Report a Decline in Earnings: What to Look Out for

Emergent Biosolutions (EBS) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

HC Andersen Capital Events 17/02: Mød topledelsen i Bavarian Nordic

HC Andersen Capital afholder i dag et spændende event, hvor du kan møde og stille spørgsmål direkte til topledelsen. Det…